Hunan Warrant Pharmaceutical Co. Ltd. A Asset Resilience Ratio
Hunan Warrant Pharmaceutical Co. Ltd. A asset resilience ratio. Hunan Warrant Pharmaceutical Co. Ltd. A (688799) has an Asset Resilience Ratio of 0.40% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See operational self-sufficiency of Hunan Warrant Pharmaceutical Co. Ltd. A to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Hunan Warrant Pharmaceutical Co. Ltd. A (2021–2024)
Asset resilience ratio of Hunan Warrant Pharmaceutical Co. Ltd. A from 2021 to 2024. This chart shows how Hunan Warrant Pharmaceutical Co. Ltd. A's Asset Resilience Ratio has changed over time. Read Hunan Warrant Pharmaceutical Co. Ltd. A (688799) financial obligations for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Hunan Warrant Pharmaceutical Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 688799 total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥10.00 Million | 0.4% |
| Total Liquid Assets | CN¥10.00 Million | 0.40% |
Asset Resilience Insights
- Limited Liquidity: Hunan Warrant Pharmaceutical Co. Ltd. A maintains only 0.40% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Hunan Warrant Pharmaceutical Co. Ltd. A Industry Peers by Asset Resilience Ratio
Compare Hunan Warrant Pharmaceutical Co. Ltd. A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773 |
Drug Manufacturers - Specialty & Generic | 29.37% |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267 |
Drug Manufacturers - Specialty & Generic | 0.01% |
|
Shenzhen Chipscreen Biosciences Co
SHG:688321 |
Drug Manufacturers - Specialty & Generic | 5.10% |
|
Cronos Group Inc
TO:CRON |
Drug Manufacturers - Specialty & Generic | 69.94% |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557 |
Drug Manufacturers - Specialty & Generic | 0.29% |
|
HPGC Renmintongtai Pharmaceutical Corp
SHG:600829 |
Drug Manufacturers - Specialty & Generic | 0.00% |
Hunan Warrant Pharmaceutical Co. Ltd. A Asset Resilience Ratio by Year (2021–2024)
Hunan Warrant Pharmaceutical Co. Ltd. A asset resilience ratio by year from 2021 to 2024. The table below shows the annual Asset Resilience Ratio data for Hunan Warrant Pharmaceutical Co. Ltd. A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 7.44% | CN¥183.00 Million ≈ $26.78 Million |
CN¥2.46 Billion ≈ $359.92 Million |
+6.75pp |
| 2023-12-31 | 0.69% | CN¥15.00 Million ≈ $2.19 Million |
CN¥2.18 Billion ≈ $318.56 Million |
-15.49pp |
| 2022-12-31 | 16.18% | CN¥325.00 Million ≈ $47.56 Million |
CN¥2.01 Billion ≈ $293.98 Million |
-6.08pp |
| 2021-12-31 | 22.25% | CN¥400.00 Million ≈ $58.53 Million |
CN¥1.80 Billion ≈ $263.04 Million |
-- |
About Hunan Warrant Pharmaceutical Co. Ltd. A
Hunan Warrant Pharmaceutical Co.,Ltd manufactures and sells pharmaceutical products. It offers medicines in the areas of digestive, berating, anti-infection, gynecology, cardiovascular, cerebrovascular, immunology and nephrology, and other fields. Hunan Warrant Pharmaceutical Co.,Ltd was founded in 2001 and is based in Changsha, China.